You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Generic Imatinib

Showing 1 - 25 of 1,161
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Generic Imatinib Compared to Glivec® in Real-Life Management of

Not yet recruiting
  • Chronic Myeloid Leukemia
  • Cairo, Egypt
  • +1 more
Mar 16, 2022

Generic Imatinib in Chronic Myeloid Leukemia Patients in Egypt

Completed
  • Philadelphia Chromosome-positive Chronic Myeloid Leukemia in Chronic Phase
  • Cairo, Egypt
    National Cancer Institute (NCI)
Feb 22, 2021

Philadelphia Chromosome Positive CML, BCR-ABL Positive Chronic Myelogenous Leukemia Trial in France (Ponatinib, Imatinib)

Recruiting
  • Philadelphia Chromosome Positive CML
  • BCR-ABL Positive Chronic Myelogenous Leukemia
  • Amiens, France
  • +27 more
Dec 9, 2021

CML, Chronic Myelogenous Leukemia, Leukemia, Myeloid Chronic Trial in Worldwide (Asciminib add-on, Imatinib, Nilotinib)

Recruiting
  • CML
  • +3 more
  • Asciminib add-on
  • +3 more
  • Augusta, Georgia
  • +46 more
Jan 23, 2023

Clinical Research of Drug Holiday Based on MRD Detection in GIST

Recruiting
  • Gastrointestinal Stromal Tumors
    • Beijing, Beijing, China
      Peking University People's Hospital
    May 11, 2023

    Gastrointestinal Stromal Tumors (GISTs) Trial in Seoul (Imatinib Mesylate)

    Completed
    • Gastrointestinal Stromal Tumors (GISTs)
    • Imatinib Mesylate
    • Seoul, Korea, Republic of
      Asan Medical Center
    Dec 30, 2022

    Melanoma Stage III, Melanoma Stage IV Trial in San Francisco (Binimetinib, Imatinib)

    Recruiting
    • Melanoma Stage III
    • Melanoma Stage IV
    • San Francisco, California
      University of California, San Francisco
    Dec 6, 2022

    Inherited Bone Marrow Failure Syndrome, Familial Platelet Disorder With Predisposition to Myeloid Malignancies Trial run by the

    Not yet recruiting
    • Inherited Bone Marrow Failure Syndrome
    • Familial Platelet Disorder With Predisposition to Myeloid Malignancies
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Oct 20, 2023

    Lung Cancer Trial in Busan (Ultrathin bronchoscopy with intratumoral washing)

    Not yet recruiting
    • Lung Cancer
    • Ultrathin bronchoscopy with intratumoral washing
    • Busan, Korea, Republic of
      Pusan National University hospital
    Nov 17, 2023

    Dyslipidemia Trial in Seoul (Rosuvastatin Immediate-Release Tablet (IRT) 10mg, Rosuvastatin orally disintegrating tablet

    Recruiting
    • Dyslipidemia
    • Rosuvastatin Immediate-Release Tablet (IRT) 10mg
    • Rosuvastatin orally disintegrating tablet (SUVARO®ODT) 10mg
    • Seoul, Korea, Republic of
      Division of Cardiology, Department of Internal Medicine, Yonsei
    Nov 22, 2023

    Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial in Canada, United States (Dasatinib, Imatinib Mesylate, Laboratory

    Active, not recruiting
    Has Results
    • Chronic Myelogenous Leukemia, BCR-ABL1 Positive
    • Burbank, California
    • +340 more
    Jan 28, 2023

    CML Trial in Tempe (Imatinib Mesylate, IkT-001Pro)

    Recruiting
    • CML
    • Tempe, Arizona
      Celerion
    Nov 21, 2022

    Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Minimal Residual Disease Trial in United States (drug, other,

    Recruiting
    • Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
    • Minimal Residual Disease
    • Goodyear, Arizona
    • +237 more
    Jan 3, 2023

    Gastrointestinal Stromal Tumor of Rectum Trial in Fuzhou (Imatinib Mesylate, Local resection)

    Not yet recruiting
    • Gastrointestinal Stromal Tumor of Rectum
    • Imatinib Mesylate
    • Local resection
    • Fuzhou, Fujian, China
      Weizhong Jiang
    Jul 23, 2023

    Sarcoma Trial in Helsinki (Imatinib)

    Recruiting
    • Sarcoma
    • Helsinki, Finland
      Helsinki University Central Hospital
    Sep 26, 2022

    Gastrointestinal Stromal Tumors Trial in Tokyo (Pimitespib, Imatinib, Sunitinib)

    Recruiting
    • Gastrointestinal Stromal Tumors
    • Tokyo, Japan
      A site selected by Taiho Pharmaceutical Co., Ltd.
    Aug 4, 2022

    Ph+ ALL Trial in China (Olverembatinib, Imatinib)

    Recruiting
    • Ph+ ALL
    • Chongqing, Chongqing, China
    • +8 more
    Sep 22, 2023

    Eosinophilic Myeloid Tumor, Hypereosinophilic Syndrome Trial run by the National Institute of Allergy and Infectious Diseases

    Recruiting
    • Eosinophilic Myeloid Neoplasm
    • Hypereosinophilic Syndrome
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 25, 2023

    Leukemia Trial in Worldwide (Dasatinib)

    Active, not recruiting
    Has Results
    • Leukemia
    • Birmingham, Alabama
    • +173 more
    Dec 1, 2022

    Breast Cancer Trial in United States (gemcitabine HCl, imatinib mesylate)

    Terminated
    Has Results
    • Breast Cancer
    • gemcitabine hydrochloride
    • imatinib mesylate
    • Chicago, Illinois
    • +8 more
    Aug 12, 2022

    Gastrointestinal Stromal Tumors Trial in Seoul (Rivoceranib Mesylate, Paclitaxel)

    Not yet recruiting
    • Gastrointestinal Stromal Tumors
    • Rivoceranib Mesylate, Paclitaxel
    • Seoul, Korea, Republic of
      Asan Medical Center, University of Ulsan College of Medicine
    Jun 7, 2023

    Unresectable Gastrointestinal Stromal Tumor (GIST), Locally Advanced Gastrointestinal Stromal Tumor (GIST), Metastatic

    Recruiting
    • Unresectable Gastrointestinal Stromal Tumor (GIST)
    • +2 more
    • Atezolizumab 1200 mg
    • Imatinib 400 MG
    • Lyon, Rhône, France
    • +4 more
    Apr 28, 2022

    Gastrointestinal Stromal Tumors Trial in Seoul (Paclitaxel)

    Recruiting
    • Gastrointestinal Stromal Tumors
    • Seoul, Korea, Republic of
      Asan Medical Center
    Dec 30, 2022

    Anemia Trial in Baltimore (sodium ferric gluconate (brand), sodium ferric gluconate (generic))

    Completed
    Has Results
    • Anemia
    • Brand sodium ferric gluconate
    • Generic sodium ferric gluconate
    • Baltimore, Maryland
      University of Maryland
    Sep 5, 2022

    Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia, Mixed Phenotype Acute Leukemia Trial in Worldwide (procedure,

    Recruiting
    • Acute Lymphoblastic Leukemia
    • +3 more
    • Allogeneic Hematopoietic Stem Cell Transplantation
    • +21 more
    • Birmingham, Alabama
    • +219 more
    Sep 15, 2022